Related Experiment Video

Updated: Jul 18, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

The ACCF/AHA Scientific Statement on Syncope: a document in need of thoughtful revision

David G Benditt1,

  • 1Cardiovascular Division, Cardiac Arrhythmia Center, University of Minnesota Medical School, Mail Code 508, 420 Delaware St SE, Minneapolis, MN 55455, USA. bendi001@umn.edu

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
|December 7, 2006
PubMed

Insights

The ACCF/AHA Syncope Statement offers guidance but may be mistaken for a guideline. Experts caution it fails to correct clinical errors in syncope evaluation, potentially harming patient care and physicians.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Ethics

Background:

  • The American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) published a Scientific Statement on syncope evaluation.
  • This statement aimed to guide clinicians but was not intended as formal practice guidelines.
  • In North America, it may be perceived as a de facto guideline due to the absence of established guidelines.

Purpose of the Study:

  • To critically evaluate the ACCF/AHA Scientific Statement on the Evaluation of Syncope.
  • To highlight potential shortcomings and misinterpretations of the statement by clinicians.
  • To address concerns regarding the impact on patient care and the legal implications for physicians.

Main Methods:

  • A commentary submitted by a multidisciplinary consortium of over 60 physicians.
  • Expert review and critique of the ACCF/AHA Syncope Statement.
  • Analysis of the statement's potential to perpetuate existing clinical errors in syncope management.

Main Results:

  • The ACCF/AHA Syncope Statement, while providing guidance, fails to address critical clinical errors in evaluating transient loss of consciousness (TLOC).
  • The statement's recommendations may lead to inadequate patient care.
  • There is a risk of a damaging legal environment for physicians managing TLOC patients.

Conclusions:

  • The current ACCF/AHA Syncope Statement requires revision to prevent inadequate patient care and legal risks.
  • Physicians evaluating syncope and TLOC need clear, accurate guidance to avoid established clinical errors.
  • The statement's potential misinterpretation as a definitive guideline necessitates careful consideration and revision.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...